Established in 2015, Xgene Pharmaceutical, Inc. engineers high-impact medications for unmet underserved needs in neurological conditions. Xgene’s proprietary linker technology generates novel dual-acting conjugates combining two well-characterized and efficacious therapeutic molecules to produce a targeted multimodal approach. The conjugated prodrug molecules exhibit different – modified by the linker – absorption, pharmacokinetic, and metabolic characteristics as compared to either parent drug. Preclinical studies of these conjugates demonstrate that the Xgene’s linker modification results in lower toxicity and superior efficacy in several conditions characterized by high unmet need.

Our Vision

Our vision is to develop superior products by leveraging clinical knowledge and basic research to achieve better treatment for patients.

Our Mission

Our mission is to bring more effective, safer products to market with efficient development process.

Leadership Team

Gene Hsu

CEO/Founder

Feng Xu

CSO/Founder

Yi Wang

Human Resources
Senior Vice President

Tsung-Wen Kuo

Vice President of

Clinical Development

for Asia Pacific

Lan Hong

Head of

Manufacturing & CMC

Iwona Beczkowska

Head of

Business Development

Eldon Chang

Director of

Administration and

Finance

Gene Hsu

CEO/Founder

Feng Xu

CSO/Founder

Yi Wang

Human Resources
Senior Vice President

Tsung-Wen Kuo

Vice President of

Clinical Development

for Asia Pacific

Lan Hong

Head of

Manufacturing & CMC

Iwona Beczkowska

Head of

Business Development

Eldon Chang

Director of

Administration and

Finance

Board Of Directors

Gene Hsu

Chairman

Feng Xu

Director

Stephen H. Ip

Independent Director

Lily Shen

Director

Jayson Lee

Director

Advisory Board

Dr. Stephan A.

Shug

Peter G.

Lacauture

Dr. Revati

Shreeniwas

Allen G. Downs

Investors

Xgene has completed 2 rounds of financing: Round A 2016 Q1; Round B 2018 Q4; Round C financing is ongoing

 

For more information, contact Dr. Iwona Beczkowska, Exec. Director Business Development, iwona.beczkowska@xgenepharm.com